Use of emerging tobacco products in the United States.
Use of emerging tobacco products in the United States.
复制标题
DOI：
10.1155/2012/989474
复制
发表时间：
2012
影响因子：
--
通讯作者：
Winickoff J
中科院分区：
文献类型：
--
作者：
McMillen R;Maduka J;Winickoff J
本文首次提供了四种新兴产品使用的全国代表性估计数。为了解决用手机替代固定电话的问题，我们使用了一个混合模式的调查，以获得两个有代表性的美国成年人样本。在3，240名符合条件的受访者中，74%完成了调查。在加权分析中，13.6%的人尝试过至少一种新兴烟草产品; 5.1%的鼻烟; 8.8%的水管; 0.6%的可溶性烟草产品; 1.8%的电子尼古丁输送系统（ENDS）产品。每日吸烟者（25.1%）和非每日吸烟者（34.9%）最有可能尝试过至少一种这些产品，与前吸烟者（17.2%）和从不吸烟者（7.7%）相比，P<0.001。18.2%的18-24岁的年轻人和12.8%的24岁以上的年轻人尝试过这些产品，P<0.01。在多变量分析中，（5.5，4.3-7.6），非每日（6.1，4.0-9.3）和既往吸烟状况（2.7，2.1-3.6）仍然显著，年轻人也是如此。（2.2，1.6-3.0）;男性（3.5，2.8-4.5）;高等教育程度;一些大学（2.7，1.7-4.2）;大学学位（2.0，1.3-3.3）。使用这些产品引起了人们对非吸烟者尼古丁依赖风险和当前吸烟者保持依赖的担忧。提高对新出现的烟草制品流行率和高风险人口使用群体的认识，可能有助于确定适当的公共卫生政策和管制行动。
This paper provides the first nationally representative estimates for use of four emerging products. Addressing the issue of land-line substitution with cell phones, we used a mixed-mode survey to obtain two representative samples of US adults. Of 3,240 eligible respondents contacted, 74% completed surveys. In the weighted analysis, 13.6% have tried at least one emerging tobacco product; 5.1% snus; 8.8% waterpipe; 0.6% dissolvable tobacco products; 1.8% electronic nicotine delivery systems (ENDS) products. Daily smokers (25.1%) and nondaily smokers (34.9%) were the most likely to have tried at least one of these products, compared to former smokers (17.2%) and never smokers (7.7%), P<.001. 18.2% of young adults 18–24 and 12.8% of those >24 have tried one of these products, P<.01. In multivariable analysis, current daily (5.5, 4.3–7.6), nondaily (6.1, 4.0–9.3), and former smoking status (2.7, 2.1–3.6) remained significant, as did young adults (2.2, 1.6–3.0); males (3.5, 2.8–4.5); higher educational attainment; some college (2.7, 1.7–4.2); college degree (2.0, 1.3–3.3). Use of these products raises concerns about nonsmokers being at risk for nicotine dependence and current smokers maintaining their dependence. Greater awareness of emerging tobacco product prevalence and the high risk demographic user groups might inform efforts to determine appropriate public health policy and regulatory action.